Search alternatives:
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
wt decrease » _ decrease (Expand Search), a decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
wt decrease » _ decrease (Expand Search), a decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
13841
Table_2_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx
Published 2022“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
-
13842
Table_7_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx
Published 2022“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
-
13843
Table_1_Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.DOCX
Published 2020“…In patients’ sera, we titrated MuSK-specific IgG (MuSK-IgG) and MuSK-IgG4, along with total IgG and IgG4 levels. …”
-
13844
Image_1_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF
Published 2022“…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”
-
13845
Table_1_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx
Published 2022“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
-
13846
Table_5_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx
Published 2022“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
-
13847
Table 2_Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.docx
Published 2025“…Among these 26 patients, 50% (13/26) experienced reversion within 24 weeks, and 80.77% within 48 weeks; thereafter, the number of reversions gradually decreased. …”
-
13848
Image_2_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF
Published 2022“…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”
-
13849
Table 1_Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.docx
Published 2025“…Among these 26 patients, 50% (13/26) experienced reversion within 24 weeks, and 80.77% within 48 weeks; thereafter, the number of reversions gradually decreased. …”
-
13850
Presentation_1_Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver F...
Published 2018“…Sy-HPBCD was found to be the most potent anti-fibrotic complex. We demonstrated that Sy-HPBCD and Sy-RAMEB complexes decreased extracellular matrix accumulation by inhibiting HSC activation and diminished the oxidative damage. …”
-
13851
DataSheet_7_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13852
DataSheet_6_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13853
Data_Sheet_1_Effect of breathing intervention in patients with COVID and healthcare workers.docx
Published 2022“…D-dimer was the primary outcome, which remained below 0.50 μg/ml (a cutoff value to define severity) in the COVID-positive yoga group (CYG) and decreased in the COVID-recovered yoga group (RYG) and the HCW yoga group (HYG) after intervention. …”
-
13854
DataSheet_9_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13855
DataSheet_1_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13856
DataSheet_2_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13857
DataSheet_4_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13858
DataSheet_10_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Car...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13859
DataSheet_8_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
-
13860
DataSheet_3_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc...
Published 2021“…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”